arazlo

Generic: tazarotene

Labeler: bausch health us, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name arazlo
Generic Name tazarotene
Labeler bausch health us, llc
Dosage Form LOTION
Routes
TOPICAL
Active Ingredients

tazarotene .45 mg/g

Manufacturer
Bausch Health US, LLC

Identifiers & Regulatory

Product NDC 0187-2098
Product ID 0187-2098_06456968-fe83-2c27-e063-6294a90af3ea
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA211882
Listing Expiration 2026-12-31
Marketing Start 2019-12-19

Pharmacologic Class

Established (EPC)
retinoid [epc]
Chemical Structure
retinoids [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01872098
Hyphenated Format 0187-2098

Supplemental Identifiers

RxCUI
2267561 2267566
UNII
81BDR9Y8PS
NUI
N0000175607 M0018962

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name arazlo (source: ndc)
Generic Name tazarotene (source: ndc)
Application Number NDA211882 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • .45 mg/g
source: ndc
Packaging
  • 10 TUBE in 1 CARTON (0187-2098-10) / 3 g in 1 TUBE (0187-2098-03)
  • 1 TUBE in 1 CARTON (0187-2098-45) / 45 g in 1 TUBE
source: ndc

Packages (2)

0187-2098-10 10 TUBE in 1 CARTON (0187-2098-10) / 3 g in 1 TUBE (0187-2098-03) 0187-2098-45 1 TUBE in 1 CARTON (0187-2098-45) / 45 g in 1 TUBE

Ingredients (1)

tazarotene (.45 mg/g)

Linked Drug Pages (1)

Arazlo ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TOPICAL"], "spl_id": "06456968-fe83-2c27-e063-6294a90af3ea", "openfda": {"nui": ["N0000175607", "M0018962"], "unii": ["81BDR9Y8PS"], "rxcui": ["2267561", "2267566"], "spl_set_id": ["d941ff25-c221-4a55-8012-0dcf3bbcbbd1"], "pharm_class_cs": ["Retinoids [CS]"], "pharm_class_epc": ["Retinoid [EPC]"], "manufacturer_name": ["Bausch Health US, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "10 TUBE in 1 CARTON (0187-2098-10)  / 3 g in 1 TUBE (0187-2098-03)", "package_ndc": "0187-2098-10", "marketing_start_date": "20191219"}, {"sample": false, "description": "1 TUBE in 1 CARTON (0187-2098-45)  / 45 g in 1 TUBE", "package_ndc": "0187-2098-45", "marketing_start_date": "20191219"}], "brand_name": "Arazlo", "product_id": "0187-2098_06456968-fe83-2c27-e063-6294a90af3ea", "dosage_form": "LOTION", "pharm_class": ["Retinoid [EPC]", "Retinoids [CS]"], "product_ndc": "0187-2098", "generic_name": "tazarotene", "labeler_name": "Bausch Health US, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Arazlo", "active_ingredients": [{"name": "TAZAROTENE", "strength": ".45 mg/g"}], "application_number": "NDA211882", "marketing_category": "NDA", "marketing_start_date": "20191219", "listing_expiration_date": "20261231"}